Organon & Co | OGN - Trade Creditors


Organon & Co reported $1.07B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Celltrion KRW 104.19B 15.67B Sep/2025
Cspc Pharmaceutical CNY 2.09B 42.45M Jun/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Glaxosmithkline GBP 21.07B 7.42B Sep/2025
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Merck USD 4.15B 102M Sep/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Novartis USD 4.56B 49M Sep/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Organon & Co USD 1.07B 7M Sep/2025
Ovoca Bio EUR 209K 242K Dec/2024
Pharma Mar EUR 54.34M 10.54M Dec/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Sartorius EUR 323.2M 61M Sep/2025
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tilray USD 107.35M 8.43M Mar/2025